Role of Fibroblast-Derived MT1-MMP in Oral Cancer
成纤维细胞衍生的 MT1-MMP 在口腔癌中的作用
基本信息
- 批准号:6921232
- 负责人:
- 金额:$ 7.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-04-01 至 2007-03-31
- 项目状态:已结题
- 来源:
- 关键词:cell growth regulationcell linecell migrationdisease /disorder modelenzyme mechanismextracellular matrixfibroblastsgene expressionhuman tissuelaboratory mousemetalloendopeptidasesmetastasismixed tissue /cell culturemouth neoplasmsneoplastic growthprotease inhibitorprotein localizationsmall interfering RNAsquamous cell carcinomatransfection /expression vectorxenotransplantation
项目摘要
DESCRIPTION (provided by applicant): Oral cavity squamous cell carcinoma (OCSCC), like many epithelial tumors, is composed of not only carcinoma cells but supporting stroma containing extracellular matrix, fibroblasts, inflammatory cells, and endothelial cells. Broadly, our lab seeks to understand mechanisms by which tumor-associated fibroblasts promote tumor proliferation and metastasis. Tumor invasion is in part mediated by the elaboration of proteinases in the tumor microenvironment that cleave surrounding extracellular matrix, chemokines, and other growth promoting molecules. The role for tumor-associated fibroblasts in tumor proliferation was recently suggested by localization of matrix metalloproteases (MMPs) primarily to surrounding fibroblasts in breast and OCSCC tumors, rather than the tumor cells. Membrane type-1 MMP (MT1-MMP) has been implicated in promoting tumor cell invasion by direct extracellular matrix degradation, activation of other MMPs, and altering tumor cell adhesion. Although identified in tumor-associated fibroblasts in OCSCC, the functional role of fibroblast-derived MT1-MMP in vivo has not been determined. We hypothesize that fibroblast-derived MT1-MMP promotes a tumor microenvironment permissive to tumor cell invasion and metastasis. To test this hypothesis we propose to assess the potential of fibroblasts to promote in vitro and in vivo OCSCC tumor cell line invasion during co-culture with 1) MT1-MMP deficient and wild-type murine fibroblasts, or 2) MT1-MMP vector or control vector transfected fibroblasts.
描述(由申请人提供):与许多上皮肿瘤一样,口腔鳞状细胞癌(OCSCC)不仅由癌细胞组成,还由含有细胞外基质、成纤维细胞、炎性细胞和内皮细胞的支持基质组成。从广义上讲,我们的实验室旨在了解肿瘤相关成纤维细胞促进肿瘤增殖和转移的机制。肿瘤侵袭部分由肿瘤微环境中蛋白酶的加工介导,所述蛋白酶切割周围的细胞外基质、趋化因子和其他生长促进分子。肿瘤相关的成纤维细胞在肿瘤增殖中的作用最近被认为是由定位的基质金属蛋白酶(MMPs)主要是周围的成纤维细胞在乳腺癌和口腔鳞状细胞癌肿瘤,而不是肿瘤细胞。膜1型MMP(MT 1-MMP)通过直接降解细胞外基质、激活其他MMP和改变肿瘤细胞粘附而参与促进肿瘤细胞侵袭。虽然在OCSCC中的肿瘤相关成纤维细胞中鉴定,但成纤维细胞衍生的MT 1-MMP在体内的功能作用尚未确定。我们推测成纤维细胞来源的MT 1-MMP促进了允许肿瘤细胞侵袭和转移的肿瘤微环境。为了检验这一假设,我们建议评估成纤维细胞在与1)MT 1-MMP缺陷型和野生型鼠成纤维细胞或2)MT 1-MMP载体或对照载体转染的成纤维细胞共培养期间促进体外和体内OCSCC肿瘤细胞系侵袭的潜力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
EBEN L. ROSENTHAL其他文献
EBEN L. ROSENTHAL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('EBEN L. ROSENTHAL', 18)}}的其他基金
Targeted Dual Modality Imaging for Detection and Removal of Head and Neck Cancer
用于头颈癌检测和切除的靶向双模态成像
- 批准号:
10671612 - 财政年份:2022
- 资助金额:
$ 7.25万 - 项目类别:
Targeted Dual Modality Imaging for Detection and Removal of Head and Neck Cancer
用于头颈癌检测和切除的靶向双模态成像
- 批准号:
10508399 - 财政年份:2022
- 资助金额:
$ 7.25万 - 项目类别:
Phase I - II Study of Ad/PNP(IND14271,1/19/10)for HNSCC(OrphanDrugDes,14-4438,6/8/15)
Ad/PNP(IND14271,1/19/10)用于 HNSCC 的 I - II 期研究(OrphanDrugDes,14-4438,6/8/15)
- 批准号:
9586709 - 财政年份:2018
- 资助金额:
$ 7.25万 - 项目类别:
Phase I - II Study of Ad/PNP(IND14271,1/19/10)for HNSCC(OrphanDrugDes,14-4438,6/8/15)
Ad/PNP(IND14271,1/19/10)用于 HNSCC 的 I - II 期研究(OrphanDrugDes,14-4438,6/8/15)
- 批准号:
10496780 - 财政年份:2018
- 资助金额:
$ 7.25万 - 项目类别:
Phase I - II Study of Ad/PNP(IND14271,1/19/10)for HNSCC(OrphanDrugDes,14-4438,6/8/15)
Ad/PNP(IND14271,1/19/10)用于 HNSCC 的 I - II 期研究(OrphanDrugDes,14-4438,6/8/15)
- 批准号:
9727786 - 财政年份:2018
- 资助金额:
$ 7.25万 - 项目类别:
Phase I - II Study of Ad/PNP(IND14271,1/19/10)for HNSCC(OrphanDrugDes,14-4438,6/8/15)
Ad/PNP(IND14271,1/19/10)用于 HNSCC 的 I - II 期研究(OrphanDrugDes,14-4438,6/8/15)
- 批准号:
10164616 - 财政年份:2018
- 资助金额:
$ 7.25万 - 项目类别:
Prototype optical device for image guided surgery with panitumumab-IRDye800
用于使用帕尼单抗-IRDye800进行图像引导手术的原型光学装置
- 批准号:
8969649 - 财政年份:2015
- 资助金额:
$ 7.25万 - 项目类别:
Prototype optical device for image guided surgery with panitumumab-IRDye800
用于使用帕尼单抗-IRDye800进行图像引导手术的原型光学装置
- 批准号:
9342705 - 财政年份:2015
- 资助金额:
$ 7.25万 - 项目类别:
相似海外基金
Establishment of a Mouse NK Cell Line for Analyzing Tumor Infiltration Processes and Developing a Preclinical Model for Cancer Immunotherapy.
建立小鼠 NK 细胞系,用于分析肿瘤浸润过程并开发癌症免疫治疗的临床前模型。
- 批准号:
23K06731 - 财政年份:2023
- 资助金额:
$ 7.25万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Proof of usefulness of PDX derived cell line
PDX 衍生细胞系的有用性证明
- 批准号:
23K06616 - 财政年份:2023
- 资助金额:
$ 7.25万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A novel producer cell line for more efficient manufacturing of viral vector systems
用于更有效地制造病毒载体系统的新型生产细胞系
- 批准号:
10597799 - 财政年份:2023
- 资助金额:
$ 7.25万 - 项目类别:
Genestorian: a web application to document and trace genetic modifications in model organism and cell line collections.
Genestorian:一个网络应用程序,用于记录和追踪模型生物和细胞系集合中的遗传修饰。
- 批准号:
EP/Y024591/1 - 财政年份:2023
- 资助金额:
$ 7.25万 - 项目类别:
Fellowship
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10672364 - 财政年份:2022
- 资助金额:
$ 7.25万 - 项目类别:
Developing a stable cell line expressing recombinant sclerostin
开发表达重组硬化素的稳定细胞系
- 批准号:
10385037 - 财政年份:2022
- 资助金额:
$ 7.25万 - 项目类别:
Development of Natural Killer (NK) Cell Line-Derived Extracellular Vesicles as a New Treatment for Cancer
开发自然杀伤 (NK) 细胞系衍生的细胞外囊泡作为癌症的新治疗方法
- 批准号:
10383462 - 财政年份:2022
- 资助金额:
$ 7.25万 - 项目类别:
A cell culture management platform to improve biomedical reproducibility by combining cell line tracking, low-cost genetic analysis, and riskassessment
细胞培养管理平台,通过结合细胞系追踪、低成本遗传分析和风险评估来提高生物医学重现性
- 批准号:
10483063 - 财政年份:2022
- 资助金额:
$ 7.25万 - 项目类别:
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10546865 - 财政年份:2022
- 资助金额:
$ 7.25万 - 项目类别:
Modulating expression of candidate genes to improve lentiviral vector production in stable cell line
调节候选基因的表达以提高稳定细胞系中慢病毒载体的产量
- 批准号:
2752732 - 财政年份:2022
- 资助金额:
$ 7.25万 - 项目类别:
Studentship














{{item.name}}会员




